Clinical · Bioinfo & AI
Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer
This study performed an integrated clinicogenomic analysis on over 7,000 colorectal cancer (CRC) samples to characterize its genetic drivers and metastatic tropisms. Researchers found that genomic evolutionary changes, such as clonal mutations and oncogenic mutant allelic imbalance, enhance the impact of recurrent oncogenic alterations. The study identified the relative timing of organ-specific metastasis, showing sequential progression in microsatellite stable CRC, with brain and adrenal metastases as late events. It also revealed clustering of metastatic sites and genomic events that modify metastasis risk, with WNT pathway activation being protective and RAS pathway activation increasing the risk of widespread metastasis. These data suggest that integrating information about primary tumor location and genomics can predict organ-specific metastasis risk.